{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:54:27Z","timestamp":1788310467748,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25686-x","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:35:49Z","timestamp":1764081349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of CXCL8 as a potential gene associated with lymph node metastasis in papillary thyroid carcinoma through bioinformatics analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Fenglei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"25686_CR1","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti, S. et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, Tre atment and follow-up\u2020. Ann. Oncol. 30, 1856\u20131883 (2019).","journal-title":"Ann. Oncol."},{"key":"25686_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12022-024-09843-y","volume":"35","author":"O Mete","year":"2024","unstructured":"Mete, O. et al. Correction: Consensus statement: recommendations on actionable Bi Omarker testing for thyroid cancer management. Endocr. Pathol. 35, 309\u2013310 (2024).","journal-title":"Endocr. Pathol."},{"key":"25686_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41574-020-00448-z","volume":"17","author":"M Schlumberger","year":"2021","unstructured":"Schlumberger, M. & Leboulleux, S. Current practice in patients with differentiated Th Yroid cancer. Nat. Rev. Endocrinol. 17, 176\u2013188 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"25686_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"25686_CR5","first-page":"1234","volume":"1","author":"JM Oh","year":"2022","unstructured":"Oh, J. M. & Ahn, B. C. Molecular mechanisms of radioactive iodine refractoriness in differ entiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics 1 (2), 1234\u20131256 (2022).","journal-title":"Theranostics"},{"key":"25686_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-030-62658-7_3","volume":"1302","author":"S Asokan","year":"2021","unstructured":"Asokan, S. & Bandapalli, O. R. CXCL8 signaling in the tumor microenvironment. Adv. Exp. Med. Biol. 1302, 25\u201339 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"25686_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s10120-023-01384-3","volume":"26","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. FAK\/IL-8 axis promotes the proliferation and migration of gastric Canc Er cells. Gastric Cancer. 26, 528\u2013541 (2023).","journal-title":"Gastric Cancer"},{"key":"25686_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12672-024-01475-2","volume":"15","author":"Y Yin","year":"2024","unstructured":"Yin, Y. et al. CXCL8 May serve as a potential biomarker for predicting the prognosi s and immune response in cervical cancer. Discov Onc. 15, 601 (2024).","journal-title":"Discov Onc"},{"key":"25686_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12935-024-03229-0","volume":"24","author":"F Li","year":"2024","unstructured":"Li, F. et al. Elucidating the role of pyroptosis in papillary thyroid cancer: prognostic, immunological, and therapeutic perspectives. Cancer Cell. Int. 24, 45 (2024).","journal-title":"Cancer Cell. Int."},{"key":"25686_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/gb-2010-11-12-220","volume":"11","author":"A Oshlack","year":"2010","unstructured":"Oshlack, A., Robinson, M. D. & Young, M. D. From RNA-seq reads to differential expression results. Genome Biol. 11, 220 (2010).","journal-title":"Genome Biol."},{"key":"25686_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"25686_CR12","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1038\/s41598-020-69290-7","volume":"10","author":"MS Sosa","year":"2020","unstructured":"Sosa, M. S. et al. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation. Sci. Rep. 10, 12345 (2020).","journal-title":"Sci. Rep."},{"key":"25686_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7863\/ultra.34.1.1","volume":"34","author":"JH Lee","year":"2015","unstructured":"Lee, J. H. et al. Sonographic and cytopathologic correlation of papillary thyroid carci Noma variants. J. Ultrasound Med. 34, 1\u201315 (2015).","journal-title":"J. Ultrasound Med."},{"key":"25686_CR14","doi-asserted-by":"publisher","first-page":"900836","DOI":"10.3389\/fonc.2022.900836","volume":"12","author":"X Luo","year":"2022","unstructured":"Luo, X. et al. FOXP4-AS1 inhibits papillary thyroid carcinoma proliferation and M igration through the Akt signaling pathway. Front. Oncol. 12, 900836 (2022).","journal-title":"Front. Oncol."},{"key":"25686_CR15","unstructured":"Limaiem, F., Rehman, A. & Mazzoni, T. Papillary Thyroid Carcinoma. In StatPearls (StatPearls Publishing, 2025)."},{"key":"25686_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier, S., Gouwy, M. & Proost, P. The chemokines CXCL8 and CXCL12: Molecu Lar and functional properties, role in disease and efforts towards Pharmacological Inte rvention. Cell. Mol. Immunol. 20, 217\u2013251 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"25686_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","volume":"10","author":"RC Russo","year":"2014","unstructured":"Russo, R. C., Garcia, C. C., Teixeira, M. M. & Amaral, F. A. The CXCL8\/IL-8 Che mokine family and its receptors in inflammatory diseases. Expert Rev. Clin. Immunol. 10, 593\u2013619 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"25686_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","volume":"31","author":"Q Liu","year":"2016","unstructured":"Liu, Q. et al. The CXCL8-CXCR1\/2 pathways in cancer. Cytokine Growth Factor Rev. 31, 61\u201371 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"25686_CR19","doi-asserted-by":"publisher","first-page":"eabh4050","DOI":"10.1126\/sciadv.abh4050","volume":"8","author":"T Walle","year":"2022","unstructured":"Walle, T. et al. Radiotherapy orchestrates natural killer cell dependent antitumor imm Une responses through CXCL8. Sci. Adv. 8, eabh4050 (2022).","journal-title":"Sci. Adv."},{"key":"25686_CR20","doi-asserted-by":"publisher","first-page":"BSR20171021","DOI":"10.1042\/BSR20171021","volume":"37","author":"R Yan","year":"2017","unstructured":"Yan, R., Shuai, H., Luo, X., Wang, X. & Guan, B. The clinical and prognostic Valu e of CXCL8 in cervical carcinoma patients: immunohistochemical analysis. Biosci. Re P. 37, BSR20171021 (2017).","journal-title":"Biosci. Re P"},{"key":"25686_CR21","first-page":"6677","volume":"8","author":"FA Khan","year":"2015","unstructured":"Khan, F. A., Al-Jameil, N., Khan, M. F., Al-Rashid, M. & Tabassum, H. Thyroid dy sfunction: an autoimmune aspect. Int. J. Clin. Exp. Med. 8, 6677\u20136681 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"25686_CR22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.21037\/tcr-20-2539","volume":"10","author":"L Gu","year":"2021","unstructured":"Gu, L., Yao, Y. & Chen, Z. An inter-correlation among chemokine (C-X-C motif) Lig and (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients. Transl. Cancer Res. 10, 748\u2013758 (2021).","journal-title":"Transl. Cancer Res."},{"key":"25686_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41401-022-00927-1","volume":"44","author":"Z Zhao","year":"2023","unstructured":"Zhao, Z. et al. Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediate d oxaliplatin resistance in gastric cancer cells via blocking PI3K\/Akt signaling. Acta Pharmacol. Sin. 44, 178\u2013188 (2023).","journal-title":"Acta Pharmacol. Sin"},{"key":"25686_CR24","doi-asserted-by":"crossref","unstructured":"Korbecki, J. et al. CXCR2 Regulation of Expression, Signal Transduction, and Involvement in Cancer. IJMS 23, 2168 (2022).","DOI":"10.3390\/ijms23042168"},{"key":"25686_CR25","unstructured":"Cahyanur, R. et al. CXCL8, MMP1, MMP2, and FN1 Gene Expression and Tumor Extension in Nasopharyngeal Cancer Patients: A Cross-sectional Study. Gene Expressi on 55, (2023)."},{"key":"25686_CR26","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. Identification of PANoptosis-based signature for predicting the progn osis and immunotherapy response in AML. Heliyon 10, e40267 (2024).","DOI":"10.1016\/j.heliyon.2024.e40267"},{"key":"25686_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano, L., Jord\u0101o, M. J. C. & Joyce, J. A. Therapeutic targeting of the tumor M icroenvironment. Cancer Discov. 11, 933\u2013959 (2021).","journal-title":"Cancer Discov"},{"key":"25686_CR28","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"25686_CR29","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen, C., Wang, Z., Ding, Y. & Qin, Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front. Immunol. 14, 1133308 (2023).","journal-title":"Front. Immunol."},{"key":"25686_CR30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1080\/15548627.2018.1476809","volume":"14","author":"J Mei","year":"2018","unstructured":"Mei, J. et al. Suppression of autophagy and HCK signaling promotes PTGS2high FC GR3\u2009\u2013\u2009NK cell differentiation triggered by ectopic endometrial stromal cells. Autopha Gy. 14, 1376\u20131397 (2018).","journal-title":"Autopha Gy"},{"key":"25686_CR31","doi-asserted-by":"crossref","unstructured":"Zhao, X. et al. CXCL8 modulates M0 macrophage proliferation and polarization to i nfluence tumor progression in cervical cancer. Sci Rep 15, 790 (2025).","DOI":"10.1038\/s41598-024-81726-y"},{"key":"25686_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1182\/blood-2005-04-1342","volume":"107","author":"W Vermi","year":"2006","unstructured":"Vermi, W. et al. Role of dendritic cell-derived CXCL13 in the pathogenesis of Barto Nella Henselae B-rich granuloma. Blood 107, 454\u2013462 (2006).","journal-title":"Blood"},{"key":"25686_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13075-016-1158-z","volume":"18","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE. Arthritis Res. Ther. 18, 263 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"25686_CR34","doi-asserted-by":"publisher","first-page":"101481","DOI":"10.1016\/j.smim.2021.101481","volume":"52","author":"AE Marciscano","year":"2021","unstructured":"Marciscano, A. E. & Anandasabapathy, N. The role of dendritic cells in cancer and anti-tumor immunity. Semin Immunol. 52, 101481 (2021).","journal-title":"Semin Immunol."},{"key":"25686_CR35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ar.22430","volume":"295","author":"G Zhang","year":"2012","unstructured":"Zhang, G. et al. Distribution change of mast cells in human nasal polyps. Anat. Rec (Hoboken). 295, 758\u2013763 (2012).","journal-title":"Anat. Rec (Hoboken)"},{"key":"25686_CR36","doi-asserted-by":"publisher","first-page":"14004","DOI":"10.3390\/ijms232214004","volume":"23","author":"AG Solimando","year":"2022","unstructured":"Solimando, A. G., Desantis, V. & Ribatti, D. Mast cells and interleukins. Int. J. Mol. Sci. 23, 14004 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"25686_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/vaccines4030022","volume":"4","author":"JM David","year":"2016","unstructured":"David, J. M., Dominguez, C., Hamilton, D. H. & Palena, C. The IL-8\/IL-8R axis: A double agent in tumor immune resistance. Vaccines (Basel). 4, 22 (2016).","journal-title":"Vaccines (Basel)"},{"key":"25686_CR38","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/2159-8290.CD-22-0886","volume":"13","author":"FX Danlos","year":"2023","unstructured":"Danlos, F. X. et al. Genomic instability and protumoral inflammation are associated with primary resistance to Anti-PD-1 + Antiangiogenesis in malignant pleural Mesot helioma. Cancer Discov. 13, 858\u2013879 (2023).","journal-title":"Cancer Discov"},{"key":"25686_CR39","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"25686_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"25686_CR41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-023-06230-z","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang, R. et al. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple- negative breast cancer progression and enhances the efficacy of anti-PD-1 Immunothe Rapy. Cell. Death Dis. 14, 703 (2023).","journal-title":"Cell. Death Dis."},{"key":"25686_CR42","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","volume":"68","author":"C Lin","year":"2019","unstructured":"Lin, C. et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut 68, 1764\u20131773 (2019).","journal-title":"Gut"},{"key":"25686_CR43","first-page":"5","volume":"9","author":"S Li","year":"2021","unstructured":"Li, S. et al. Molecular subtypes of oral squamous cell carcinoma based on immun osuppression genes using a deep learning approach. Front. Cell. Dev. Biol. 9, 68724 5 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"8","key":"25686_CR44","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.32604\/or.2025.063716","volume":"33","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Mitochondrial pyruvate dehydrogenase phosphatase metabolism disorder in malignant tumors. Oncol. Res. 33 (8), 1861\u20131874 (2025).","journal-title":"Oncol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25686-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25686-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25686-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:35:52Z","timestamp":1764081352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25686-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25686"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25686-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of Gansu Province People\u2019s Hospital (Approval Number:2022\u2009\u2212\u2009182) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"41771"}}